Safety, Tolerability, and Pharmacokinetics of Single Ascending Oral Doses of INV-101 in Healthy Male and Female Subjects
Clinical trial NCT04531150 · COMPLETED
Trial details
- NCT number
- NCT04531150
- Sponsor
- Inversago Pharma Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-08
- Primary completion
- 2021-01-16
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.